New and other treatments remain effective but are reaching doctors in quantities that are no match for the Omicron surge.
Tag: Regeneron Pharmaceuticals Inc
W.H.O. Backs Antibody Treatment For High-Risk Covid Patients
The expensive treatment, developed by the U.S. drug maker Regeneron and the Swiss biotech company Roche, has garnered attention as backstop for those who shun vaccines.
Vaccines Are Effective Against the New York Variant, Studies Find
The research adds to a growing number of findings suggesting the Pfizer and Moderna shots are protective against the variants identified so far.
Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
How the Out-of-Control Pandemic Is Speeding the Testing of Vaccines
The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.
The Race for a Super-Antibody Against the Coronavirus
A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans.
A Cure for Ebola? Two New Treatments Prove Highly Effective in Congo
The therapies saved roughly 90 percent of the patients who were newly infected, a turning point in the decades-long fight against the virus.